InspireMD (NSPR) Free Cash Flow Growth (5y) (2015 - 2025)
InspireMD (NSPR) Free Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | InspireMD | 58.53 Mn | 4.32 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33.92% |
| Sep 30, 2025 | -24.11% |
| Jun 30, 2025 | -43.13% |
| Mar 31, 2025 | -31.20% |
| Dec 31, 2024 | -34.22% |
| Sep 30, 2024 | -26.02% |
| Jun 30, 2024 | -10.02% |
| Mar 31, 2024 | -8.17% |
| Dec 31, 2023 | -19.01% |
| Sep 30, 2023 | -17.72% |
| Jun 30, 2023 | -8.70% |
| Mar 31, 2023 | -22.21% |
| Dec 31, 2022 | -12.87% |
| Sep 30, 2022 | -20.70% |
| Jun 30, 2022 | -15.03% |
| Mar 31, 2022 | -7.46% |
| Dec 31, 2021 | -9.43% |
| Sep 30, 2021 | -7.76% |
| Jun 30, 2021 | -26.60% |
| Mar 31, 2021 | -14.48% |